TITLE 856 INDIANA BOARD OF PHARMACY

Temporarily amends 856 IAC 2-2-2 to add drug compounds to Schedule I. Repeals LSA Document #22-41(E), posted at 20220223-IR-856220041ERA. Statutory authority: IC 25-26-13-4.1. Effective 30 days after filing with the Publisher.

SECTION 1. (a) This SECTION is supplemental to 856 IAC 2-2-2.

(b) Unless specifically excepted or unless listed in another schedule, any of the following substances, including its analogs, isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such analogs, isomers, esters, ethers, and salts is possible within the specific chemical designation:

(1) Mesocarb (N-phenyl-N -(3-(1- phenylpropan-2-yl)-1,2,3-oxadiazol-3- ium-5-yl)carbamimidate.

(2) Amineptine (7-[(10,11-dihydro-5H- dibenzo[a,d]cyclohepten-5- yl)amino]heptanoic acid.

(3) Tianeptine (7-[(3-chloro-6-methyl-5,5-dioxo-11H-benzo[c][2,1]benzothiazepin-11-yl)amino]heptanoic acid), also known as Tianeptine sodium powder, Tianna, Tianna Green, Tianna red, and Tianna White.

DIN: 20230111-IR-856230001ERA

Composed: May 02,2024 2:53:07PM EDT

A PDF version of this document.